Exane Derivatives’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $966 | Hold |
90
| – | – | ﹤0.01% | 507 |
|
|
2022
Q1 | $852 | Hold |
90
| – | – | ﹤0.01% | 813 |
|
|
2021
Q4 | $1.04K | Hold |
90
| – | – | ﹤0.01% | 695 |
|
|
2021
Q3 | $859 | Hold |
90
| – | – | ﹤0.01% | 860 |
|
|
2021
Q2 | $822 | Hold |
90
| – | – | ﹤0.01% | 877 |
|
|
2021
Q1 | $889 | Hold |
90
| – | – | ﹤0.01% | 726 |
|
|
2020
Q4 | $2.08K | Hold |
90
| – | – | ﹤0.01% | 609 |
|
|
2020
Q3 | $1.27K | Hold |
90
| – | – | ﹤0.01% | 572 |
|
|
2020
Q2 | $1.36K | Sell |
90
-1,701
| -95% | -$25.6K | ﹤0.01% | 515 |
|
|
2020
Q1 | $16.5K | Sell |
1,791
-7,009
| -80% | -$64.8K | ﹤0.01% | 390 |
|
|
2019
Q4 | $91.4K | Hold |
8,800
| – | – | 0.02% | 313 |
|
|
2019
Q3 | $70.6K | Hold |
8,800
| – | – | 0.01% | 333 |
|
|
2019
Q2 | $110K | Hold |
8,800
| – | – | 0.02% | 308 |
|
|
2019
Q1 | $120K | Hold |
8,800
| – | – | 0.02% | 263 |
|
|
2018
Q4 | $84.3K | Hold |
8,800
| – | – | 0.02% | 307 |
|
|
2018
Q3 | $106K | Hold |
8,800
| – | – | 0.02% | 292 |
|
|
2018
Q2 | $137K | Buy |
+8,800
| New | +$137K | 0.02% | 271 |
|